Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus
Clinical trial NCT06227221 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06227221
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.